Letter: the ethics of using inferior regimens in H. pylori randomised trials
Author:
Publisher
Wiley
Subject
Pharmacology (medical),Gastroenterology,Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2036.2011.04944.x/fullpdf
Reference19 articles.
1. Randomised clinical trial: the efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy for Helicobacter pylori in Korea;Kim;Aliment Pharmacol Ther,2011
2. Effects of CYP2C19 and MDR1 genotype on the eradication rate of Helicobacter pylori infection by triple therapy with pantoprazole, amoxycillin and clarithromycin;Oh;J Gastroenterol Hepatol,2009
3. Effectiveness of 10 day-sequential therapy for Helicobacter pylori eradication in Korea;Choi;Korean J Gastroenterol,2008
4. Preoperative versus postoperative Helicobacter pylori eradication therapy in gastric cancer patients: a randomized trial;Kim;Am J Gastroenterol,2008
5. H. pylori eradication: a randomized prospective study of triple therapy with or without ecabet sodium;Kim;World J Gastroenterol,2008
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Sequential versus Standard Triple Therapy for First-Line Helicobacter pylori Eradication: An Update;Antibiotics;2024-01-30
2. Empiric H. pylori therapy—10-day concomitant, bismuth quadruple or 14-day triple therapy: none is best;Translational Cancer Research;2016-12
3. Sequential Therapy versus Triple Therapy for the First Line Treatment of Helicobacter pylori in Korea: A Nationwide Randomized Trial;Gut and Liver;2016-07-15
4. Systematic review with meta-analysis: the efficacy of levofloxacin triple therapy as the first- or second-line treatments ofHelicobacter pyloriinfection;Alimentary Pharmacology & Therapeutics;2016-06-30
5. Sequential versus standard triple first-line therapy for Helicobacter pylori eradication;Cochrane Database of Systematic Reviews;2016-06-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3